Bonesupport Holding AB (publ) (STO:BONEX)

Market Cap	12.41B
Revenue (ttm)	1.12B
Net Income (ttm)	151.92M
Shares Out	65.86M
EPS (ttm)	2.28
PE Ratio	82.71
Forward PE	40.80
Dividend	n/a
Ex-Dividend Date	n/a

Volume	348,230
Average Volume	283,857
Open	183.90
Previous Close	183.80
Day's Range	183.90 - 189.10
52-Week Range	182.40 - 405.80
Beta	0.47
RSI	34.50
Earnings Date	Feb 24, 2026

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute t...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1999
• Employees: 139
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BONEX

Financial Performance

In 2024, Bonesupport Holding AB's revenue was 898.73 million, an increase of 52.05% compared to the previous year's 591.08 million. Earnings were 133.75 million, a decrease of -45.41%.